Clinical Trial Update: Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial updates magrolimab for recurrent or progressive malignant brain tumors in children and adults; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• Magrolimab (magrolimab)

Snippet

Sponsor: University of California, San Francisco | Conditions: Brain Cancer, Malignant Brain Tumor | Phase 1 | Status: COMPLETED